Condition
Blood Glucose Fluctuations
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (2)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06340087Early Phase 1CompletedPrimary
Impact Hesperetin in Combination with Sucrose on Blood Glucose Regulation
NCT05705596Early Phase 1CompletedPrimary
Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
NCT04011683Completed
Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes
Showing all 3 trials